Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.59 |
| ▸ | MAPT | P10636 | 2/20 | 0.59 |
| ▸ | MEN1 | O00255 | 1/20 | 0.59 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.59 |
| ▸ | CA12 | O43570 | 6/20 | 0.45 |
| ▸ | CA1 | P00915 | 6/20 | 0.45 |
| ▸ | CA2 | P00918 | 6/20 | 0.45 |
| ▸ | CA7 | P43166 | 6/20 | 0.45 |
| ▸ | CA9 | Q16790 | 6/20 | 0.45 |
| ▸ | CA14 | Q9ULX7 | 6/20 | 0.45 |
| ▸ | ESR1 | P03372 | 1/20 | 0.45 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.45 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.44 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 2/20 | 0.43 |
| ▸ | GAA | P10253 | 2/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26932379 | 0.92 | KDM4E (0.52) | KDM4EMAPTMEN1ALOX15KMT2A | |
| SCHEMBL9548196 | 0.83 | KDM4E (0.72) | KDM4EMAPTMEN1ALOX15KMT2A | |
| SCHEMBL15247080 | 0.82 | KDM4E (0.64) | KDM4EMAPTMEN1ALOX15KMT2A | |
| SCHEMBL5954131 | 0.82 | KDM4E (0.53) | KDM4EMAPTMEN1ALOX15KMT2A | |
| SCHEMBL317949 | 0.78 | MAPT (0.50) | KDM4EMAPTMEN1ALOX15KMT2A | |
| SCHEMBL2620018 | 0.78 | MAPT (0.50) | KDM4EMAPTMEN1ALOX15KMT2A | |
| SCHEMBL5608026 | 0.78 | KDM4E (0.59) | KDM4EMAPTMEN1ALOX15KMT2A | |
| SCHEMBL13579596 | 0.78 | KDM4E (0.46) | KDM4EMAPTMEN1ALOX15KMT2A | |
| SCHEMBL7595192 | 0.77 | — | — | |
| SCHEMBL17629568 | 0.77 | KDM4E (0.52) | KDM4EMAPTMEN1ALOX15KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115232008-B | Compound, preparation method thereof and application of compound in preparation of fluroxypyr intermediate | 山东潍坊润丰化工股份有限公司 | 2024-05-17 | — | — | CN | disclosed |
| US-20240010605-A1 | COMPOUND, PREPARATION METHOD THEREFOR AND APPLICATION OF COMPOUND IN PREPARATION OF BICYCLOPYRONE INTERMEDIATE | SHANDONG WEIFANG RAINBOW CHEMICAL CO.,LTD (CN) | 2024-01-11 | — | — | US | disclosed |
| WO-2023237027-A1 | COMPOUND, METHOD FOR PREPARING SAME, AND USE THEREOF IN PREPARING BICYCLOPYRONE INTERMEDIATE | 山东潍坊润丰化工股份有限公司 | 2023-12-14 | — | — | WO | disclosed |
| CN-115232008-A | Compound, preparation method thereof and application of compound in preparation of fluroxypyr intermediate | 山东潍坊润丰化工股份有限公司 | 2022-10-25 | — | — | CN | disclosed |
| CN-114716320-B | Compound, preparation method thereof and application of compound in preparation of fluroxypyr intermediate | 山东潍坊润丰化工股份有限公司 | 2022-09-27 | — | — | CN | disclosed |
| CN-114716320-A | Compound, preparation method thereof and application of compound in preparation of fluroxypyr intermediate | 山东潍坊润丰化工股份有限公司 | 2022-07-08 | — | — | CN | disclosed |
| US-20020090532-A1 | Electroluminescent arrangement using doped blend systems | HEUER HELMUT-WERNER (DE) | 2002-07-11 | — | — | US | disclosed |
| US-6376107-B1 | CONTAINING QUINACRIDONE COMPOUND | BAYER AKTIENGESELLSCHAFT (DE) | 2002-04-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240010605-A1 | COMPOUND, PREPARATION METHOD THEREFOR AND APPLICATION OF COMPOUND IN PREPARATION OF BICYCLOPYRONE INTERMEDIATE | WEE1, WEE2, CYP4F11 | KDM4E 4226/4885MAPT 864/4885MEN1 1693/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.